Qualigen Therapeutics Presents Data on QN-302 at AACR's

Posters include data regarding 1) mode of action, and 2) preclinical toxicology CARLSBAD, Calif., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Qualigen...

Related Keywords

Boston ,Massachusetts ,United States ,American ,Stephen Neidle ,Jules Abraham ,Tariq Arshad ,Ahmed ,Exchange Commission ,Partners Inc ,American Academy Of Cancer Research ,Qualigen Therapeutics Inc ,Aboutqualigentherapeutics Inc ,Nasdaq ,Orphan Drug Designation ,American Academy ,Cancer Research ,Special Conference ,Pancreatic Cancer ,Chief Medical ,Investigational New Drug ,Qualigen Therapeutics ,Fast Track ,Orphan Drug ,Private Securities Litigation Reform Act ,Nasdaq Qlgn ,Nc ,Algn ,Racr ,N 302 ,